Clinical Performance of Capillary Blood Samples Collected Using the Tasso+ Serum Gel Capillary Blood Collection System for Clinical Chemistry Testing of 14 Analytes on an Abbott Alinity Analyzer

Part of paid clinical trials in Atlantis, Florida.

Sponsor
Tasso Inc.
Study ID
NCT07260799
Status
Recruiting

Conditions

  • Serum Analytes

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Accepted

Interventions

  • Tasso+ Serum Gel Capillary Blood Collection System — DIAGNOSTIC_TEST
    Clinical evaluation of capillary blood samples collected using the Tasso+ Serum Gel Capillary Blood Collection System for downstream analyte testing.

Study Details

The purpose of this single-visit study is to demonstrate the performance of capillary blood samples collected with the Tasso+ Serum Gel Capillary Blood Collection System compared to venous reference samples for downstream analyte testing at a clinical laboratory.

Key Dates

Start date
Oct 25, 2025
Status verified
Mar 2026
Primary completion
May 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
150 participants (estimated)

Arms

  • Arm: Tasso+ Serum Gel Capillary Blood Collection System
    Comparison of serum analyte results from capillary blood collected using the Tasso+ Serum Gel Capillary Blood Collection System vs. venous blood obtained via traditional venipuncture.

Primary Outcome Measure

Number participants for which there is statistical equivalence between serum biomarker results obtained from capillary blood vs. venous blood [ Time Frame: 48 Hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Celesta / American Research LabsAtlantisFlorida33462
Scientific Director
561-801-5835
Sri Madireddy, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Atlantis, FL